All GLP-1 weight loss drugs articles
-
NewsTesco targets ‘smaller appetites’ diet boom with nutrient dense range
The Plentifuel range comes with supermarkets responding to the challenge of growth in the use of weight-loss medications
-
Category ReportProtein continues to flex its muscles
Brits are going potty for protein. Which brands are winning the power struggle?
-
NewsPlant-based meal box brand Grubby partners with Tim Spector on gut-friendly recipe range
Each meal kit arrives with pre-portioned whole food ingredients, easy-to-follow recipe cards, and details on the specific ‘gut and mood benefits’ of each dish.
-
Category ReportCakes and biscuits harness the power of confectionery
All top five biscuit brands and four of the top five cake brands are in volume decline
-
Comment & OpinionEditor’s picks: supermarkets struggle for growth, Tesco supplier row, delivery robots
With the rumour mill in overdrive over consolidation in the grocery sector, we look at why they’re struggling for growth. Plus Tesco’s supplier row, Diageo’s innovation shake-up and delivery robots
-
NewsGLP-1 drugs have little impact on family meal choices
Parents taking GLP-1 weight-loss drugs such as Mounjaro or Wegovy are adapting their own eating habits rather than overhauling what their families eat, according to new Mumsnet research
-
NewsSimple Online Pharmacy rapped by regulator over weight-loss pill ads
Ads for prescription-only medicine are by banned under the Committee of Advertising Practice Code
-
NewsCrops have lost up to 50% of core nutrients, report warns
The report found that this nutritional loss combined with the rise of GLP-1 drugs could push around five million UK working-age adults below safe levels of essential vitamins and minerals
-
WhitepapersHow shoppers will be eating, spending and buying in 2027
Get the facts behind the fmcg hype as real-life shoppers reveal which food trends really shape their shop.
-
NewsWeight-loss drugs to fuel rise of smaller plates in 2027, says Bidfood
The foodservice wholesaler has predicted ‘Mini & Mighty’ dishes will drive growth for operators, such as right-sized bowls, sliders, snack pots, mini desserts and grazing plates
-
Comment & OpinionWhere does UPF fit in the future of convenience food?
Three experts give their take on how concerns over UPFs will shape convenience food
-
NewsGLP-1s drive rebound in snacking category M&A, analysis finds
The popularisation of GLP-1 weight-loss drugs has driven a rebound in M&A in snacking companies around the world, according to analysis by investment bank Houlihan Lokey
-
Analysis & FeaturesThe weight-loss boom reshaping the dairy sector
For GLP-1 users with smaller appetites, every calorie counts – and dairy is caught in the crossroads of functionality and indulgence
-
Partner FeaturesFunctional focus: reaching the new functional food shopper
With functional food now mainstream in Britain, this fast-growing category represents a huge opportunity for retailers and suppliers to create healthy profits.
-
NewsPret and Gail’s explore more high-protein options amid GLP-1 boom
Pret CEO said food-to-go chain is looking at how it can introduce protein more prevalently across different categories
-
NewsSainsbury’s head of healthy and sustainable diets on fibre, meal deals and GLP-1s
Sritharan discussed how Sainsbury’s is looking to promote healthy and affordable diets, the changing landscape of health, and how the wider sector and the government can play their part
-
WhitepapersHow to cater to the new functional consumer
Functional food has gone mainstream. In this new report, we reveal new consumer insight, emerging trends and practical strategies to help retailers and suppliers unlock the functional health opportunity.
-
Comment & OpinionEditor’s picks: Tesco tackles UPFs, Mounjaro mishap, inflation reprieve
As Tesco made a decisive move in the UPF debate, a Grocer reporter obtained Mounjaro and Christmas started to look less pricey for consumers
-
Comment & OpinionGLP-what?! It should not have been this easy to buy Mounjaro
It was shockingly easy for our reporter to get hold of Mounjaro. The regulator is understandably concerned
-
NewsRegulator ‘very concerned’ by MedExpress weight-loss prescription investigation
Exclusive investigation reveals MedExpress approved a Mounjaro prescription for a patient with a BMI of 22.5 after unverified weight data was submitted, prompting concern from the pharmacy regulator